Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasciola hepatica | 24 | 2023 | 31 | 9.040 |
Why?
|
| Helminth Proteins | 12 | 2025 | 23 | 5.630 |
Why?
|
| Fascioliasis | 15 | 2018 | 16 | 3.850 |
Why?
|
| Fatty Acid-Binding Proteins | 6 | 2025 | 24 | 3.630 |
Why?
|
| Antigens, Helminth | 12 | 2018 | 34 | 3.220 |
Why?
|
| Antibodies, Helminth | 13 | 2018 | 24 | 2.730 |
Why?
|
| Macrophages | 7 | 2025 | 515 | 2.330 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2025 | 64 | 2.080 |
Why?
|
| Cytokines | 8 | 2023 | 661 | 1.840 |
Why?
|
| Lipopolysaccharides | 5 | 2025 | 235 | 1.820 |
Why?
|
| Saposins | 8 | 2018 | 10 | 1.750 |
Why?
|
| Shock, Septic | 3 | 2019 | 19 | 1.310 |
Why?
|
| Immunoglobulin G | 7 | 2024 | 253 | 1.280 |
Why?
|
| NF-kappa B | 2 | 2025 | 355 | 1.250 |
Why?
|
| Glutathione Transferase | 3 | 2019 | 90 | 1.190 |
Why?
|
| Antibodies, Neutralizing | 4 | 2024 | 118 | 1.180 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2025 | 128 | 1.110 |
Why?
|
| Proteomics | 2 | 2025 | 363 | 1.070 |
Why?
|
| Antibodies, Viral | 4 | 2024 | 295 | 0.990 |
Why?
|
| Vaccination | 7 | 2024 | 332 | 0.960 |
Why?
|
| Animals | 28 | 2025 | 16695 | 0.940 |
Why?
|
| Phagosomes | 1 | 2025 | 33 | 0.940 |
Why?
|
| Mice | 15 | 2025 | 6490 | 0.900 |
Why?
|
| Leukocytes | 1 | 2025 | 79 | 0.900 |
Why?
|
| Colitis, Ulcerative | 1 | 2025 | 68 | 0.880 |
Why?
|
| Colon | 1 | 2025 | 118 | 0.870 |
Why?
|
| Macrophages, Peritoneal | 2 | 2023 | 23 | 0.810 |
Why?
|
| Sepsis | 1 | 2023 | 90 | 0.780 |
Why?
|
| Inflammation | 3 | 2025 | 729 | 0.750 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 456 | 0.720 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 26 | 0.720 |
Why?
|
| Dendritic Cells | 1 | 2021 | 130 | 0.680 |
Why?
|
| Mice, Inbred BALB C | 7 | 2021 | 686 | 0.670 |
Why?
|
| Rabbits | 8 | 2018 | 292 | 0.660 |
Why?
|
| Inclusion Bodies | 2 | 2018 | 34 | 0.630 |
Why?
|
| Oxidative Stress | 1 | 2025 | 990 | 0.610 |
Why?
|
| Vaccines, Synthetic | 3 | 2010 | 78 | 0.610 |
Why?
|
| Schistosoma mansoni | 2 | 2011 | 21 | 0.600 |
Why?
|
| Protein Engineering | 1 | 2018 | 47 | 0.570 |
Why?
|
| Serologic Tests | 6 | 2022 | 45 | 0.500 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 147 | 0.490 |
Why?
|
| RNA, Messenger | 4 | 2024 | 1265 | 0.480 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 1554 | 0.470 |
Why?
|
| Cell Movement | 1 | 2018 | 640 | 0.450 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 79 | 0.450 |
Why?
|
| Signal Transduction | 2 | 2025 | 2111 | 0.440 |
Why?
|
| Macrophage Activation | 1 | 2014 | 59 | 0.430 |
Why?
|
| Escherichia coli | 4 | 2023 | 461 | 0.430 |
Why?
|
| Parasitology | 1 | 2013 | 2 | 0.430 |
Why?
|
| Apoptosis | 1 | 2021 | 1541 | 0.420 |
Why?
|
| Recombinant Proteins | 5 | 2018 | 522 | 0.420 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 602 | 0.410 |
Why?
|
| Humans | 20 | 2024 | 42163 | 0.380 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 51 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1804 | 0.380 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 24 | 0.350 |
Why?
|
| Ferritins | 1 | 2011 | 63 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 303 | 0.320 |
Why?
|
| Proteome | 1 | 2011 | 150 | 0.310 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 683 | 0.310 |
Why?
|
| Female | 12 | 2024 | 24018 | 0.310 |
Why?
|
| Puerto Rico | 3 | 2023 | 1376 | 0.300 |
Why?
|
| Down-Regulation | 2 | 2025 | 452 | 0.300 |
Why?
|
| DNA, Complementary | 4 | 2011 | 195 | 0.290 |
Why?
|
| Nitric Oxide | 2 | 2025 | 381 | 0.280 |
Why?
|
| Cloning, Molecular | 3 | 2017 | 318 | 0.260 |
Why?
|
| Spleen | 3 | 2018 | 199 | 0.260 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2006 | 12 | 0.250 |
Why?
|
| Glycoproteins | 2 | 2004 | 127 | 0.250 |
Why?
|
| Epitope Mapping | 1 | 2006 | 31 | 0.250 |
Why?
|
| Epitopes | 1 | 2007 | 155 | 0.250 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1066 | 0.250 |
Why?
|
| Vaccines, DNA | 1 | 2005 | 24 | 0.240 |
Why?
|
| Mice, Knockout | 2 | 2021 | 1010 | 0.240 |
Why?
|
| Dextran Sulfate | 1 | 2025 | 17 | 0.230 |
Why?
|
| Chromatography, Affinity | 2 | 2018 | 67 | 0.230 |
Why?
|
| Peroxidase | 1 | 2025 | 57 | 0.230 |
Why?
|
| Blotting, Western | 4 | 2016 | 884 | 0.230 |
Why?
|
| Flow Cytometry | 2 | 2021 | 411 | 0.220 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 1188 | 0.220 |
Why?
|
| Zoonoses | 1 | 2024 | 20 | 0.220 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 41 | 0.210 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1617 | 0.190 |
Why?
|
| Neutralization Tests | 1 | 2021 | 55 | 0.180 |
Why?
|
| Cross Reactions | 3 | 2016 | 86 | 0.180 |
Why?
|
| Molecular Weight | 2 | 2012 | 168 | 0.180 |
Why?
|
| Male | 6 | 2025 | 22779 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1559 | 0.170 |
Why?
|
| Gene Expression | 2 | 2017 | 692 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 350 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 363 | 0.150 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 65 | 0.150 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1051 | 0.150 |
Why?
|
| Cell-Free System | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cytosol | 1 | 2018 | 98 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2018 | 75 | 0.140 |
Why?
|
| Cell Survival | 1 | 2021 | 934 | 0.140 |
Why?
|
| Protein Binding | 1 | 2021 | 1076 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2018 | 134 | 0.140 |
Why?
|
| Parasite Egg Count | 2 | 2009 | 5 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2011 | 273 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 221 | 0.130 |
Why?
|
| DNA, Helminth | 2 | 2010 | 6 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 74 | 0.130 |
Why?
|
| Cattle | 2 | 2024 | 505 | 0.130 |
Why?
|
| Mutation | 1 | 2021 | 1169 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 293 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 427 | 0.120 |
Why?
|
| Immunoglobulin E | 2 | 2007 | 59 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 73 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 379 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 117 | 0.110 |
Why?
|
| Isoelectric Focusing | 1 | 2014 | 13 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 353 | 0.110 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 52 | 0.110 |
Why?
|
| Immune Evasion | 1 | 2014 | 17 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 98 | 0.110 |
Why?
|
| Adult | 3 | 2024 | 13458 | 0.110 |
Why?
|
| Liver | 2 | 2009 | 503 | 0.110 |
Why?
|
| Integumentary System | 1 | 2013 | 1 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2017 | 875 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 223 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 67 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 254 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2016 | 541 | 0.090 |
Why?
|
| Immunologic Tests | 1 | 2011 | 11 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 973 | 0.090 |
Why?
|
| Gene Library | 1 | 2012 | 60 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 185 | 0.090 |
Why?
|
| Isoelectric Point | 1 | 2011 | 10 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 78 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 102 | 0.080 |
Why?
|
| DNA, Recombinant | 1 | 2010 | 17 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 21 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2013 | 426 | 0.080 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 35 | 0.080 |
Why?
|
| Iron | 1 | 2011 | 247 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 170 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 928 | 0.080 |
Why?
|
| DNA Primers | 1 | 2009 | 295 | 0.080 |
Why?
|
| Plasmids | 1 | 2010 | 247 | 0.070 |
Why?
|
| Aged | 1 | 2021 | 7982 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 649 | 0.070 |
Why?
|
| Phylogeny | 1 | 2011 | 740 | 0.070 |
Why?
|
| Schistosomiasis mansoni | 1 | 2006 | 10 | 0.060 |
Why?
|
| Peptide Library | 1 | 2006 | 27 | 0.060 |
Why?
|
| Middle Aged | 1 | 2021 | 11819 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1058 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 244 | 0.060 |
Why?
|
| Abortion, Veterinary | 1 | 2024 | 3 | 0.060 |
Why?
|
| Rwanda | 1 | 2024 | 6 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2024 | 19 | 0.060 |
Why?
|
| Bile | 1 | 2004 | 11 | 0.060 |
Why?
|
| Cattle Diseases | 1 | 2024 | 30 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 111 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 378 | 0.050 |
Why?
|
| Feces | 1 | 2004 | 126 | 0.050 |
Why?
|
| Sphingolipid Activator Proteins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Proteolipids | 1 | 2003 | 4 | 0.050 |
Why?
|
| RNA, Helminth | 1 | 2003 | 4 | 0.050 |
Why?
|
| Malaria | 1 | 2024 | 90 | 0.050 |
Why?
|
| Immune Sera | 1 | 2003 | 56 | 0.050 |
Why?
|
| Vagina | 1 | 2023 | 89 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 357 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 149 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 190 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2003 | 32 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 574 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 271 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 126 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 246 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 28 | 0.040 |
Why?
|
| Hookworm Infections | 1 | 2016 | 1 | 0.030 |
Why?
|
| Schistosomiasis japonica | 1 | 2016 | 1 | 0.030 |
Why?
|
| Toxocariasis | 1 | 2016 | 2 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 196 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 3942 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1266 | 0.020 |
Why?
|